Steven G Gray Selected Research

ranatachykinin C

1/2021

Detection of MET Exon 14 Skipping Alterations in Lung Cancer Clinical Samples Using a PCR-Based Approach.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Steven G Gray Research Topics

Disease

27	Neoplasms (Cancer) 02/2022 - 03/2003
24	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2021 - 11/2009
14	Lung Neoplasms (Lung Cancer) 04/2021 - 09/2009
13	Mesothelioma 02/2022 - 01/2012
8	Malignant Mesothelioma 02/2022 - 05/2012
7	Prostatic Neoplasms (Prostate Cancer) 12/2021 - 12/2012
7	Carcinogenesis 01/2019 - 08/2005
4	Rheumatoid Arthritis 04/2014 - 04/2006
4	Huntington Disease (Huntington's Disease) 08/2011 - 04/2006
3	Adenocarcinoma 04/2021 - 01/2013
3	Neoplasm Metastasis (Metastasis) 01/2018 - 03/2011
3	Inflammation (Inflammations) 03/2017 - 04/2006
2	Rare Diseases (Rare Disease) 05/2021 - 02/2020
2	Rheumatic Diseases (Rheumatism) 04/2014 - 03/2013
2	Multiple Sclerosis 04/2006 - 07/2005
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 04/2006 - 07/2005
2	Hepatoblastoma 03/2003 - 06/2002
1	Fibrosis (Cirrhosis) 02/2022
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2021
1	Residual Neoplasm 04/2021
1	Liver Neoplasms (Liver Cancer) 03/2019
1	Stomach Neoplasms (Stomach Cancer) 03/2019
1	Pathologic Processes 12/2018
1	Hepatocellular Carcinoma (Hepatoma) 05/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 08/2017
1	Cytokine Release Syndrome 03/2017
1	Genetic Translocation (Chromosomal Translocation) 01/2017
1	Psoriatic Arthritis 11/2016
1	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2016
1	Hypoxia (Hypoxemia) 01/2016

Drug/Important Bio-Agent (IBA)

11	Cisplatin (Platino)FDA LinkGeneric 02/2022 - 03/2011
9	Histone Deacetylases (Histone Deacetylase)IBA 03/2019 - 03/2003
8	Biomarkers (Surrogate Marker)IBA 12/2021 - 06/2012
8	Proteins (Proteins, Gene)FDA Link 10/2020 - 06/2002
7	Pharmaceutical PreparationsIBA 02/2022 - 07/2005
5	AsbestosIBA 05/2021 - 01/2013
5	MicroRNAs (MicroRNA)IBA 04/2021 - 02/2015
4	Untranslated RNA (Noncoding RNA)IBA 12/2021 - 12/2015
4	Circular RNAIBA 12/2021 - 01/2017
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2021 - 01/2015
4	Histone Deacetylase InhibitorsIBA 01/2015 - 07/2005
3	RNA (Ribonucleic Acid)IBA 01/2022 - 04/2018
3	Messenger RNA (mRNA)IBA 10/2020 - 01/2015
3	ElementsIBA 03/2017 - 03/2013
3	CytokinesIBA 11/2016 - 01/2013
3	Carrier Proteins (Binding Protein)IBA 04/2006 - 04/2005
2	Bevacizumab (Avastin)FDA Link 01/2022 - 02/2015
2	Pemetrexed (MTA)FDA Link 01/2022 - 03/2011
2	Formaldehyde (Formol)FDA Link 01/2022 - 01/2019
2	ParaffinIBA 01/2022 - 01/2019
2	enzalutamideIBA 12/2021 - 01/2019
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2021 - 01/2019
2	Neuropilin-1IBA 01/2020 - 02/2015
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020 - 02/2015
2	Androgen Receptors (Androgen Receptor)IBA 01/2019 - 03/2018
2	Interleukin-23 (Interleukin 23)IBA 01/2013 - 01/2013
2	Gemcitabine FDA Link 12/2012 - 03/2011
2	Vorinostat FDA Link 05/2012 - 01/2012
2	Insulin ReceptorIBA 03/2011 - 09/2007
2	trichostatin A (A 300)IBA 04/2006 - 07/2005
1	Oxidoreductases (Dehydrogenase)IBA 02/2022
1	CollagenIBA 02/2022
1	Estrogen ReceptorsIBA 01/2022
1	InterferonsIBA 05/2021
1	Immune Checkpoint InhibitorsIBA 05/2021
1	Vitamin A (Retinol)FDA LinkGeneric 04/2021
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 04/2021
1	RetinoidsIBA 04/2021
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 04/2021
1	Histone DemethylasesIBA 03/2021
1	Small Interfering RNA (siRNA)IBA 03/2021
1	Lipid NanoparticlesIBA 03/2021
1	didodecyldimethylammoniumIBA 03/2021
1	N- (1- (2,3- dioleyloxy)propyl)- N,N,N- trimethylammoniumIBA 03/2021
1	EphA2 ReceptorIBA 03/2021
1	JIB-04IBA 03/2021
1	LipidsIBA 03/2021
1	ranatachykinin CIBA 01/2021
1	Indicators and Reagents (Reagents)IBA 10/2020
1	chloropyramineIBA 10/2020
1	MethyltransferasesIBA 01/2020
1	N- (4- (2- amino- 3- chloropyridin- 4- yloxy)- 3- fluorophenyl)- 4- ethoxy- 1- (4- fluorophenyl)- 2- oxo- 1,2- dihydropyridine- 3- carboxamideIBA 01/2019
1	LCRF-0004IBA 01/2019
1	Arginine (L-Arginine)FDA Link 12/2018
1	Peptides (Polypeptides)IBA 12/2018
1	resminostatIBA 05/2018
1	napabucasinIBA 01/2018
1	C.I. Solvent Yellow 56 (DEAB)IBA 09/2017
1	Disulfiram (Antabuse)FDA Link 09/2017
1	AcidsIBA 08/2017
1	atezolizumabIBA 11/2016
1	PlatinumIBA 03/2016
1	Oxygen (Dioxygen)IBA 01/2016

Therapy/Procedure

20	Therapeutics 01/2022 - 03/2003
8	Drug Therapy (Chemotherapy) 02/2022 - 03/2011
6	Immunotherapy 02/2022 - 11/2016
2	Castration 12/2021 - 01/2019
1	Salvage Therapy 02/2020
1	Subcutaneous Injections 02/2015